After partnering with AT&T and Verizon and receiving a Zack’s Analyst Valuation target 1,832% above market price, this nano-cap tech stock could experience a huge growth period. Now is the time to watch it like a hawk!
Category: News
Senior Life Sciences Analyst From Noble Financial Says This Gene Therapy Stock Could Climb Over 400%
Robert LeBoyer, a Senior Life Sciences Analyst at Noble Financial doubled down on his Outperform rating with a 400% upside after this company signed an exclusive University license agreement.
This Prime Opportunity to Hedge Against The Looming Recession Is On Your Screen Right Now
With a market recession looming overhead and an increasing surge of online commerce, this pawn service connection app is filling a huge technical gap for millions, and our portfolios
Insiders Are Buying This Medical Tech Goldmine And It’s Breaking Out
This recent medical device stock’s moderate float breakout presented mammoth potential and insiders are amassing shares. Get your eyes on this one early!
Breakthrough Fusion Gene Map Technology Announcement Takes Hold of $15 Billion Leukemia Treatment Market
This biotech company has been flying under the radar until now. With their recent FDA Approval announcement for Fusion Gene Map Technology and a patent approval, they are primed for an industry-shaking explosion.
Phase 1 Release for This Big Data Powerhouse Means Big Opportunity
With the release of Phase 1 of Singularity and the additions of more powerful technologies, this audience acquisition powerhouse is taking full advantage of machine-learning and sustained revenue growth.
This Stock Could Go Nuclear
This company has significant connections, a high analyst target, and plenty of major catalysts on the horizon!
Huge New Gold Prediction for 2023
This stock is without a shadow of a doubt, our No. 1 idea for the gold rally. It’s catalysts are too attractive to ignore.
Massive Bounce Potential for This One Tech Stock
After Inking Deals with AT&T and Verizon, a Senior Analyst at Zacks Small Cap Research Says This Little Tech Stock Could Climb Over 1,823%…
BYND Cannasoft to See Explosive Growth in $33B Medical Cannabis Industry
Cannabis CRM, created by BYND Cannasoft Enterprises Inc., is a unique cloud-based SaaS platform for the legal cannabis industry. Find out what this means for a $33B industry.
